NCT06458946已完成不适用
Study the Postprandial Blood Glucose and Insulin in Different Fruit Snacks
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Blood glucose iAUC - 2 hours
研究概览
简要总结
The goal of this clinical trial is to compare the postprandial glucose and insulin responses after different fruit snacks compared to confection control in a healthy population
详细描述
Fruit snacks made form sweetened dried fruits are great sources of polyphenols, fiber, and other nutrients. The addition of sugar could help the taste, texture, and shelf life of this type of product. Fruit snacks with different levels of sugar were developed to meet various consumer needs and the postprandial glucose response in healthy population compared with confection control is of interest to study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
盲法说明
Tested fruit bites are masked. Confection control is hard to mask (open label).
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •≥18 to ≤45 years of age at visit
- •BMI ≥18.5 and <30.0 kg/m2 at visit
- •Fasting capillary glucose <110 mg/dL at visit
- •Willing to avoid consuming high-polyphenol containing foods for 48 h prior to each test visit.
- •Willing to abstain from alcohol consumption for 24 hours prior to each study visit.
- •Non-user of tobacco or nicotine products (e.g., cigarette smoking, vaping, chewing tobacco) within 12 months of visit 1, with no plans to begin use during the study period.
- •Willing to maintain habitual physical activity level throughout the duration of the study.
- •Willing to maintain habitual dietary pattern throughout the duration of the study, including stable intake of current vitamins, minerals, supplements and medications not interfering with study outcomes.
- •Score of 7 to 10 on the Vein Access Scale at visit
- •No health conditions that would prevent him/her from fulfilling the study requirements as judged by the Clinical Investigator on the basis of medical history.
- •Understands the study procedures and signs forms providing informed consent to participate in the study and authorizes the release of relevant protected health information to the Clinical Investigator.
排除标准
- •History or presence of clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, pancreatic, or neurological disorders that may affect the participant's ability to adhere to the study protocol and/or affect study outcomes, in the judgment of the Investigator.
- •Uncontrolled hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) as defined by the blood pressure measured at visit 1
- •Unstable use (initiation or change in dose) within 30 days of visit 1 of antihypertensive medications.
- •Unstable use (initiation or change in dose) within 30 days of visit 1 of thyroid hormone replacement medications.
- •Use of medications or supplements that may influence carbohydrate metabolism within 30 days of visit
- •Extreme dietary habits (e.g., ketogenic, very high protein, very high fiber, vegan, vegetarian) at the discretion of the Clinical Investigator.
- •Weight loss or gain >4.5 kg in the 2 months prior to visit
- •Currently, or planning to be, on a weight loss regimen during the study.
- •Use of weight loss medication within 90 d of visit
- •History of gastrointestinal surgery for weight reducing purposes.
- •History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating) diagnosed by a health professional.
- •Known allergy or sensitivity to any ingredients or potential allergens contained in the study product.
- •History or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
- •History of any major trauma or major surgical event within 2 months of visit
- •Blood donation >450 mL within 8 weeks of visit 2 or plans to donate blood or plasma during the study period.
- •Female who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential with unstable use (initiation or change in dose) within 30 days of visit 1) of sex hormones for contraception.
- •Recent history of (within 12 months of screening; visit 1) or strong potential for alcohol or substance abuse. Alcohol abuse is defined as >14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits).
- •Exposed to any non-registered drug product within 30 days prior to visit
- •Any condition the Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.
结局指标
主要结局
Blood glucose iAUC - 2 hours
时间窗: 2 hours
The primary outcome variable will be glucose incremental area under the curve (iAUC) from pre-product consumption to 120 min (iAUC0-120 min)
次要结局
- Blood glucose change(2 hours)
- blood glucose time to max concentration(2 hours)
- Blood insulin(2 hours)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Monitoring Postprandial Glycemia in Fruit SnacksBlood GlucoseNCT05961475Ocean Spray Cranberries, Inc.20
已完成
不适用
Post-prandial Glycemic Response to Fiber in Healthy AdultsGlucose, High BloodGlucose, Low BloodMealsNCT03252704Ingredion Incorporated28
已完成
不适用
Investigation of Blood Glucose and Insulin Response After Intake of VitaloseHealthy AdultsNCT04596709Beneo-Institute13
已完成
不适用
A Clinical Study to Investigate and Compare the Impact of High Protein Pasta, Lower Protein Pasta and White Rice on Blood Sugar Control in People With Type 1 Diabetes Mellitus (T1DM)Diabetes Mellitus, Type 1NCT03362151Sansum Diabetes Research Institute14
已完成
不适用
A Randomized, Controlled, Crossover Study to Assess the Glucose and Insulin Excursions of a Test FiberHealthyNCT03239288Cargill22